Home Meetings Online CME/CE Clinical Resources Amazing Charts
Currently an exhibitor? Visit our Exhibitor Resource Center for up-to-date information.

Pri-Med West 2013

Location: Anaheim, CA
Date: May 1-4, 2013

Meeting Overview

Venue:
Anaheim Convention Center
Primary Audience:
Primary Care
Credits:
Refer to the Accreditation Tab

 

As a primary care clinician, you are at the center of patient care.

Online registration for this event is now closed so that we may prepare for the program. Onsite registration opens Thursday, May 2, 2013 at 7:00 AM.

Whether diagnosing and treating an acute illness or managing patients with complex medical needs, you ensure optimal patient outcomes. Managing multiple priorities—from daily patient care to office administration—makes it difficult to leave the office and recharge.

Pri-Med Conference & Exhibition offers low-cost continuing medical education in a flexible format. The CME conference schedule is designed to maximize your time out of the office, providing clinical updates on the disease states and patients you treat daily.

  • Women’s health
  • Pediatric and adolescent medicine
  • Cardiology for primary care clinicians
  • And many more topics for CME or CE credit

Earn up to 25.75 AMA PRA Category 1 Credits™.

For 2013, Harvard Medical School and David Geffen School of Medicine at UCLA have developed a curriculum of relevant lectures so you’re primed to deliver the best patient care.

Register for Pri-Med West by: Your price*
January 11 $30
February 22 $40
April 5 $55
April 27 $75
On-site at Pri-Med West $100
Learn More about Pri-Med Conference & Exhibition »

Watch this video for five tips on getting the most out of your Pri‑Med experience:

video

Save Meeting to Your Calendar

Have any ideas on how Pri-Med can improve your continuing medical education experience? Email us; we’d love to hear what you think.

*Price represents online registration. Registration by phone is an additional $10.

Primary Care Updates tracks are sponsored by pmiCME. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

Primary Care Updates activities are produced independently of and are not affiliated with Harvard Medical School or David Geffen School of Medicine at UCLA.

 

Pri-Med West Full Conference Brochure

View the Pri-Med West
Full Conference Brochure

 

Primary Care Updates*

May 1, 2013
A multi-track day of CME programs to supplement your education.

 

Current Clinical Issues in Primary Care

May 2–4, 2013
The core continuing medical education curriculum covering the latest topics in primary care medicine.

Harvard Medical School
David Geffen School of Medicine at UCLA
 

Educational Symposia

Independent, non-Harvard Medical School accredited CME sessions to expand your learning.


Non-CME Opportunities at Pri-Med West
Be the first to know the latest innovations, technologies, and product research in the health care industry.

Exhibit Hall
Face-to-face conversations with industry professionals, helpful takeaways, and engaging floor activities.
Learn More »

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.
Learn More »

 


Sessions & Syllabus

Following is a recap of the core educational elements from the conference sessions, to help you take what you learned and apply it to your interactions with patients.
Primary Care Updates, Wednesday, May 01, 2013 | Jump to:  Track 1  Track 2  Track 3 
  Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Forest Laboratories, Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc., Merck, Novartis and sanofi-aventis U.S. Inc.
7:00 AM-7:50 AM
Registration & Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:15 AM
HPV Immunization: A Model for Cancer Prevention

Learning Objectives:

  1. Explain the epidemiology and burden of disease associated with HPV viruses
  2. Identify those HPV types most often associated with particular cancers and genital warts
  3. Explain the epidemiology and burden of disease associated with HPV viruses
Kenneth A. Alexander, MD, PhD, Professor of Pediatrics, Chief, Section of Pediatric Infectious Diseases, University of Chicago, Chicago, IL
Joel M. Palefsky, MD, FRCP (C), Professor of Medicine, School of Medicine, University of California, San Francisco, San Francisco, CA
9:15 AM-9:30 AM
AM Break
9:30 AM-10:45 AM
Clarifying the Confusion of COPD: Implementing Guidelines and Good Practice

Learning Objectives:

  1. Utilize current COPD guidelines including the use of spirometry for COPD diagnosis and monitoring for symptom control
  2. Evaluate the evidence for recommended standard and newer agents in improving COPD symptoms and decreasing exacerbations
Stephen I Rennard, MD (Read Bio), Larson Professor of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
Frank C. Sciurba, MD, FCCP, Associate Professor of Medicine and Education, Director, Emphysema/COPD Research Center, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
10:45 AM-12:15 PM
Multiple Sclerosis in a Primary Care Setting: Employing Strategies for Early Diagnosis and Improved Patient Outcomes

Learning Objectives:

  1. Recognize early MS symptoms and facilitate accurate diagnosis according to recommended MS diagnostic and imaging criteria
  2. Be familiar with strategies for managing the symptoms and complications of MS in the primary care setting
  3. Outline the risks and benefits of currently available disease modifying therapies in the treatment of patients with MS
  4. Monitor MS patients on disease modifying therapies for effectiveness and safety
Regina Radner Berkovich, MD, PhD, Assistant Professor of Clinical Neurology, University of Southern California Keck School of Medicine, Los Angeles, CA
Victor Rivera, MD, FAAN, Distinguished Emeritus Professor of Neurology, Baylor College of Medicine, Richmond, TX
12:15 PM-1:00 PM
Lunch
1:00 PM-2:30 PM
Complementary Therapies to Improve Glucose Control in Type 2 Diabetes: Role of GLP-1 Receptor Agonists & Basal Insulin

Learning Objectives:

  1. Apply strategies to individualized therapy in the treatment of patients with type 2 diabetes
  2. Incorporate appropriate strategies for timely initiation, selection, titration, and self-management of basal insulin in patients with type 2 diabetes
  3. Describe the similarities and differences between individual GLP-1 receptor agonists
  4. Summarize the clinical rationale and evidence for combining GLP-1 receptor agonists with basal insulin so as to address various underlying pathophysiologic components of type 2 diabetes
Anne Peters, FACP, CDE, MD (Read Bio), Director, USC Clinical Diabetes Program, Keck School of Medicine of USC, Los Angeles, CA
Andrew Ahmann, MD, MS, Professor of Medicine, Director, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR
2:30 PM-2:45 PM
PM Break
2:45 PM-4:00 PM
Resistance is Futile: Functional Outcomes for Major Depressive Disorder

Learning Objectives:

  1. Choose initial evidence-based depression treatment that is specifically suited to the individual patient's need
  2. Monitor patients with depression over time in order to track treatment adherence, response, and side effects
  3. Make evidence-based treatment adjustments to address residual symptoms and side effects
Peter J. Knoblich, MD, Family Practice Physician, Private Practice, Roseville, CA
  Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: Forest Research Institute, a subsidiary of Forest Laboratories, Inc., and Ironwood Pharmaceuticals, Lilly USA, LLC, Merck and Vivus.
7:00 AM-7:50 AM
Registration & Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:30 AM
Improving the Care of Patients with Chronic Pain: Individualized Assessment and Mechanism-Based Multimodal Treatment

Learning Objectives:

  1. Discuss the neurobiologic mechanisms that contribute to chronic pain and associated functional disability
  2. Assess biologic, psychological, and social factors that contribute to chronic pain via detailed patient histories, comprehensive clinical interviews, and targeted physical exams
  3. Prescribe and tailor pharmacologic regimens for chronic pain that reflect published evidence of efficacy, likely disease mechanisms, functional goals, and patient-specific risks of adverse outcomes
  4. Incorporate nonpharmacologic approaches and patient education to improve analgesia, functional gains, and treatment adherence
  5. Manage chronic pain in diverse patient populations, including older patients and patients with comorbid medical or psychiatric disorders
Bill McCarberg, MD (Read Bio), Adjunct Assistant Clinical Professor, University of California, San Diego, San Diego, CA, Founder, Chronic Pain Management Program, Kaiser Permanente, San Diego, CA, Family Practitioner, Neighborhood Health, San Diego, CA
Steven Stanos, DO (Read Bio), Assistant Professor, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of Medicine, Chicago, IL, National Director, Corporate Pain Services, Attending Physician, Center for Pain Management, Rehabilitation Institute of Chicago, Chicago, IL
Charles Argoff, MD, Professor of Neurology, Albany Medical College, Albany, NY, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY
Improving the Care of Patients with Chronic Pain session meets the California state mandated CME requirement for 1.5 AMA PRA Category 1 Credit hours.
9:30 AM-9:45 AM
AM Break
9:45 AM-11:00 AM
Improving Adult Immunization Coverage in the US

Learning Objectives:

  1. Identify adult patients for appropriateness of administering vaccines based on current recommendations
  2. Act to increase provider recommendations to patients who should be vaccinated
  3. Implement standing orders for adult immunization within practice setting
William Schaffner, MD, Professor and Chair, Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN
Robert H. Hopkins, MD, FACP, FAAP, Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR
M. Susan Burke, MD, FACP (Read Bio), Clinical Associate Professor of Medicine, Thomas Jefferson University, Philadelphia, PA
11:00 AM-12:15 PM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic

Learning Objectives:

  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
Michelle Look, FAAFP, MD, Family Practice-Sports Medicine Physician, San Diego Sports Medicine and Family Health Center, San Diego, CA
Holly R. Wyatt, MD (Read Bio), Associate Professor of Medicine, Division of Endocrine, Metabolism, and Diabetes, Associate Director, Anschutz Health and Wellness Center, University of Colorado Denver, Denver, CO
12:15 PM-1:00 PM
Lunch
1:00 PM-2:30 PM
Insulin Replacement Therapy for Type 2 Diabetes: Patient-Centered Management of Hyperglycemia in Primary Care

Learning Objectives:

  1. Discuss the multisystem consequences of T2DM and the rationale for appropriate screening, early diagnosis, and prompt treatment
  2. Establish individualized treatment goals for patients with T2DM according to disease duration, age, comorbidities, and ongoing evaluations of hemoglobin A1C, blood glucose profiles, and therapeutic responses
  3. Employ evidence-based frameworks and new treatment approaches to individualize basal and mealtime insulin therapies across diverse T2DM patient populations
  4. Integrate patient-specific clinical and psychosocial factors into comprehensive treatment plans that include lifestyle modifications and pharmacologic interventions for T2DM
  5. Educate patients with T2DM about the importance of treatment adherence and the risks of insulin-related hypoglycemia
Mark W. Stolar, MD, Associate Professor of Clinical Medicine, Feinberg School of Medicine, Northwestern University Medical School, Chicago, IL
Jeff Unger, MD, Assistant Professor of Family Medicine, Loma Linda University School of Medicine, Riverside, CA, Director, Metabolic Studies, Catalina Research Institute, Chino, CA
Derek LeRoith, MD, PhD, Director of Research, Professor of Medicine, Division of Endocrinology, Mount Sinai School of Medicine, New York, NY
2:30 PM-2:45 PM
PM Break
2:45 PM-4:00 PM
Under Pressure: The Need to Expedite IBS Diagnosis and Treatment in Primary Care

Learning Objectives:

  1. Diagnose IBS based upon symptoms that may be shared with other functional gastrointestinal disorders or organic diseases
  2. Compare and contrast the efficacy and safety of available pharmacologic and non-pharmacologic treatment options for IBS
  3. Apply appropriate and comprehensive treatment strategies to enhance the care of patients with IBS
Lawrence R. Schiller, MD, FACS (Read Bio), Professor of Internal Medicine, Texas A&M Health Science Center, Dallas Campus, Dallas, TX, Program Director, Gastroenterology Fellowship, Baylor University Medical Center, Dallas, TX
Brian E. Lacy, MD, PhD (Read Bio), Professor of Medicine, Dartmouth Medical School, Lebanon, NH, Chief, Section of Gastroenterology and Heptology, Dartmouth Hitchcock Medical Center, Lebanon, NH
  Primary Care Updates Track 3
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 3: Amarin Corporation plc, AMGEN, AstraZeneca, Novo Nordisk Inc. and Vivus.
7:00 AM-7:50 AM
Registration & Breakfast
7:50 AM-8:00 AM
Opening Remarks
8:00 AM-9:30 AM
Reducing Risk in the Acute Coronary Syndrome Patient: Insights for Primary Care Clinicians

Learning Objectives:

  1. Describe fundamental pharmacokinetics, pharmacodynamics, and pharmacogenetics of oral antiplatelet therapies.
  2. Discuss efficacy and safety data with oral antiplatelet therapies from ACS outcomes trials.
  3. Identify therapies to reduce risk and recognize goals to achieve in the management of patients who have experienced an acute coronary syndrome.
Jeffrey S Berger, MD, MS, Assistant Professor of Medicine, New York University School of Medicine, New York, NY
Jeffrey L. Anderson, MD, FACC, FAHA, MACP, Professor of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT
9:30 AM-9:45 AM
AM Break
9:45 AM-11:00 AM
A Patient’s Journey With Osteoporosis: From Diagnosis Through Treatment

Learning Objectives:

  1. Implement osteoporosis treatment guidelines regarding diagnosis and fracture prevention
  2. Initiate treatment of osteoporosis from risk assessment scores and bone mineral density
  3. Choose an appropriate treatment option for patients with osteoporosis and manage the benefit:risk ratio of short and long term therapy with pharmacologic therapies across all classes of medication
E Michael Lewiecki, FACE, MD, FACP,
Michael Maricic, MD, Clinical Associate Professor of Medicine, University of Arizona School of Medicine, Tucson, AZ
11:00 AM-12:15 PM
Tackling the Toughest Issues and Cases of Hypertriglyceridemia

Learning Objectives:

  1. Discuss the role of elevated triglyceride levels in the assessment and diagnosis of dyslipidemia, including cardiovascular risk factors
  2. Apply best practices in the attainment of TG levels, including the role of fasting and nonfasting states in accurate evaluation
  3. Evaluate the management of hypertriglyceridemia through greater adherence to evidence-based practices and accepted guidelines
  4. Select potential new and emerging therapeutic approaches to manage TG-based dyslipidemia, mixed dyslipidemia, and associated cardiovascular risk
Eliot A. Brinton, MD, FAHA, FNLA (Read Bio), President, American Board of Clinical Lipidology, Jacksonville, FL, President, Utah Lipid Center, Salt Lake City, UT, Director, Atherometabolic Research, Utah Foundation for Biomedical Research, Salt Lake City, UT
Gregory S. Pokrywka, MD, NCMP, FACP, FNLA (Read Bio), Assistant Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, Director, Baltimore Lipid Center, Baltimore, MD, Diplomate, American Board of Clinical Lipidology, Jacksonville, FL
12:15 PM-1:00 PM
Lunch
1:00 PM-2:30 PM
Case Work: Evaluating GLP-1 Receptor Agonists in Patient-Centered Care for Type 2 Diabetes

Learning Objectives:

  1. Evaluate and apply current evidence regarding GLP-1 RA efficacy relative to other agents and across diabetes progression
  2. Evaluate and apply current evidence regarding safety of GLP-1 RAs, including recent data on specific label precautions (eg, thyroid cancer, pancreatitis, renal failure) and cardiovascular disease
  3. Evaluate and apply current evidence regarding tolerability and treatment satisfaction with GLP-1 RAs
  4. Evaluate and apply current evidence regarding nonglycemic effects of GLP-1 RAs (eg, effects on weight, blood pressure, lipid levels)
Derek LeRoith, MD, PhD, Mt Sinai School of Medicine, New York, NY
Javier Morales, MD (Read Bio), Principal Clinical Trials Investigator, Advanced Internal Medicine Group, PC, Great Neck, NY
Jay Shubrook, DO, FACOFP, FAAFP, Associate Professor of Family Medicine, Director of Clinical Research, Department of Family Medicine, Director of Diabetes Fellowship, The Diabetes Institute, Ohio University Heritage College of Osteopathic Medicine, Athens, OH
2:30 PM-2:45 PM
PM Break
2:45 PM-4:00 PM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic

Learning Objectives:

  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
Michelle Look, FAAFP, MD, Family Practice-Sports Medicine Physician, San Diego Sports Medicine and Family Health Center, San Diego, CA
Holly R. Wyatt, MD (Read Bio), Associate Professor of Medicine, Division of Endocrine, Metabolism, and Diabetes, Associate Director, Anschutz Health and Wellness Center, University of Colorado Denver, Denver, CO
Thursday, May 02, 2013
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
John D. Halamka, MD
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 1: Live On-Stage Orthopedic Demonstration

9:30 AM-10:30 AM Hand Examination
Charles Day, MD (Read Bio)
10:30 AM-11:30 AM Knee Examination
James Puffer, MD (Read Bio)
Session 2: Selected Topics in Internal Medicine

9:30 AM-10:10 AM Diagnosis and Management of Rheumatoid Arthritis
Peng Fan, MD (Read Bio)
10:10 AM-10:50 AM Management of Migraine
Gerald Smetana, MD (Read Bio)
10:50 AM-11:30 AM Diagnosis and Management of Hand Infections
Charles Day, MD (Read Bio)
Session 3: Nephrology (ARS)

9:30 AM-10:10 AM Chronic Kidney Disease
Robert Stanton, MD (Read Bio)
10:10 AM-10:50 AM Approach to the Patient With Kidney Stones
Edwin Jacobson, MD (Read Bio)
10:50 AM-11:30 AM When Should a Patient with Kidney Disease be Referred to a Nephrologist
Robert Stanton, MD (Read Bio)
11:45 AM-1:15 PM Lunch Symposia
11:45 AM-1:15 PM
James R. Gavin III, MD, PhD (Read Bio), Clinical Professor of Medicine, Emory University School of Medicine, Atlanta, GA, CEO & Chief Medical Officer, Healing Our Village, Inc, Atlanta, GA
John E Anderson MD, Past President, The Frist Clinic, Nashville, TN
Davida F Kruger MSN, BC-ADM, APRN, Certified Nurse Practitioner, Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, MI, Division of Endocrinology, Diabetes and Bone Mineral Disorders, Detroit, MI
Commercial Support: The CME activity is supported by an educational grant from Novo Nordisk Inc.
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 4A: GI Medicine

1:30 PM-2:10 PM Celiac Sprue: Protean Manifestations
Daniel Leffler, MD, MS (Read Bio)
2:10 PM-2:50 PM Meeting the Challenge of C. difficile
Kevin Ghassemi, MD
2:50 PM-3:30 PM Chronic Diarrhea
Daniel Leffler, MD, MS (Read Bio)
Session 5A: Ask The Expert: Neurology, Hepatology & Rheumatology (ARS)

1:30 PM-3:30 PM Panel Discussion with questions from the audience
Peng Fan, MD (Read Bio)
Penny Greenstein, MD
Session 6A: Subspecialty Update

1:30 PM-2:10 PM Common Head and Neck Disorders
Paul Kedeshian, MD (Read Bio)
2:10 PM-2:50 PM Varicose Veins: What’s New?
David Rigberg, MD
2:50 PM-3:30 PM Common Eye Disorders
Lynn Gordon, MD
4:00 PM-6:00 PM Current Clinical Issues in Primary Care
Session 4B: Primary Care Potpourri

4:00 PM-4:40 PM Molecular Genetic Testing: Current and Future Applications
Wayne Grody, MD
4:40 PM-5:20 PM Urinary Tract Infection
Michelle Eslami, MD (Read Bio)
5:20 PM-6:00 PM Patient-Centered Clinical Approach to Common Frustrating Problems in Primary Care
Ka-Kit Hui, MD, FACP (Read Bio)
Session 5B: Cardiovascular Medicine (ARS)

4:00 PM-4:40 PM Stroke
Penny Greenstein, MD
4:40 PM-5:20 PM A Clinical Approach to Heart Failure
Jon Kobashigawa, MD (Read Bio)
5:20 PM-6:00 PM Preoperative Cardiac Evaluation: Risk Factors and Novel Risk Reduction Strategies
Gerald Smetana, MD (Read Bio)
Session 6B: Women's Health I

4:00 PM-4:40 PM Osteoporosis
Carolyn Crandall, MD (Read Bio)
4:40 PM-5:20 PM Top Stories in Women’s Health: Putting Research into Practice
Karen Carlson, MD (Read Bio)
5:20 PM-6:00 PM Cancer Screening in Women
Jodi Friedman (Read Bio)
Friday, May 03, 2013
6:15 AM-7:45 AM Breakfast Symposia
6:15 AM-7:45 AM
Commercial Support: The CME activity is supported by an educational grant from Lilly USA, LLC
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Holly G Atkinson, MD (Read Bio)
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 7: Women’s Health II (ARS)

9:30 AM-10:10 AM Menopause Update 2013
Janet Pregler, MD, FACP (Read Bio)
10:10 AM-10:50 AM Insomnia: Special Issues for Women
Karen Carlson, MD (Read Bio)
10:50 AM-11:30 AM Case Studies in Vaginitis
Martin Quan, MD (Read Bio)
Session 8: Pediatric & Adolescent Medicine

9:30 AM-10:10 AM The Surge in Celiac Disease: Challenges in Primary Care
Aubrey Katz, MB
10:10 AM-10:50 AM A Practical Approach to Pediatric Headaches
Christopher Giza, MD
10:50 AM-11:30 AM The Rise in Food Allergy: Role of Primary Care Clinicians
Aubrey Katz, MB
Session 9: Drugs: New and Old

9:30 AM-10:30 AM New Drugs for the Primary Care Provider: What You Need to Know
Gerald Smetana, MD (Read Bio)
10:30 AM-11:30 AM Old Drugs, New Thoughts
Jane Sillman, MD (Read Bio)
11:45 AM-1:15 PM Lunch Symposia
11:45 AM-1:15 PM
Commercial Support: The CME activity is supported by an educational grant from Lilly USA, LLC
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 10A: Challenges in Primary Care

1:30 PM-2:10 PM Managing Difficult-to-Treat Hypertension
Karol Watson, MD, PhD, FACC (Read Bio)
2:10 PM-2:50 PM Depression in Primary Care
Gerald Smetana, MD (Read Bio)
2:50 PM-3:30 PM Smoking Cessation: A Nuts-and-Bolts Approach
Timothy Fong
Session 11A: Pediatric & Adolescent Trends

1:30 PM-2:10 PM Childhood Obesity, Prevention and Management
Wendy Slusser, MD
2:10 PM-2:50 PM Pediatric Literature Updates
Harvey Katz, MD (Read Bio)
2:50 PM-3:30 PM The Child with Recurrent Infections
Maria Garcia-Lloret, MD
Session 12A: Medical Literature (ARS)

1:30 PM-2:30 PM What You Need to Know from the Medical Literature I
John Goodson, MD, FACP (Read Bio)
2:30 PM-3:30 PM Choosing Tests Wisely I
Jane Sillman, MD (Read Bio)
4:00 PM-6:00 PM Current Clinical Issues in Primary Care
Session 10B: Practice Innovation for Practical Use

4:00 PM-5:00 PM Team Based Care: What Works
Karen Carlson, MD (Read Bio)
Ellen Long-Middleton, PhD, RN, FNP (Read Bio)
5:00 PM-6:00 PM Understanding the Medicare Annual Wellness Visits
John Goodson, MD, FACP (Read Bio)
Session 11B: Pulmonary Medicine

4:00 PM-4:40 PM COPD: Preventable and Treatable
Christopher Fanta, MD (Read Bio)
4:40 PM-5:20 PM Asthma Update
Eric Kleerup
5:20 PM-6:00 PM Bronchiectasis: New Ideas About an Old Disease
Christopher Fanta, MD (Read Bio)
Session 12B: Sports Medicine (ARS)

4:00 PM-4:40 PM Case Studies of Lower Extremity Injuries
John DiFiori, MD (Read Bio)
4:40 PM-5:20 PM Performance Enhancing Drugs: Where Are We Now?
Gary Green, MD (Read Bio)
5:20 PM-6:00 PM Case Studies of Upper Extremity Injuries
James Puffer, MD (Read Bio)
6:15 PM-7:45 PM Dinner Symposia
6:15 PM-7:45 PM
Commercial Support: The CME activity is supported by an educational grant from Lilly USA, LLC
Saturday, May 04, 2013
7:45 AM-8:45 AM Keynote Address
7:45 AM-8:45 AM
Martin Shapiro, MD, PhD
9:30 AM-11:30 AM Current Clinical Issues in Primary Care
Session 13: End of Life

The Harvard Medical School designates this session for 2 credits in education on pain management and treatment of the terminally ill.
9:30 AM-10:10 AM Management of Pain at End-of-Life
Sue Charette
10:10 AM-10:50 AM End of Life Care: Listening to the Patient
Ellen Long-Middleton, PhD, RN, FNP (Read Bio)
10:50 AM-11:30 AM Medical Ethics at the End-of-Life
Neil Wenger, MD
Session 14: Pediatric & Adolescent Medicine Interactive Audience Participation (ARS)

9:30 AM-10:10 AM Challenging Cases: What’s the Diagnosis - Disorders of the Breast?
Harvey Katz, MD (Read Bio)
10:10 AM-10:50 AM Management of the Young Febrile Child with No Source
Carlos Lerner
10:50 AM-11:30 AM ADHD for Primary Physicians, How DSM-5 Changes Practice
Neelkamal Soares, MD
Session 15: Selected Topics in Primary Care

9:30 AM-10:10 AM Shared Decision Making
Karen Carlson, MD (Read Bio)
10:10 AM-10:50 AM STD Update
Richard Johnson, MD (Read Bio)
10:50 AM-11:30 AM Choosing Tests Wisely II
Jane Sillman, MD (Read Bio)
1:30 PM-3:30 PM Current Clinical Issues in Primary Care
Session 16: Geriatrics

The Harvard Medical School designates this session for 2 credits in education on geriatric medicine.
1:30 PM-2:10 PM Infections in the Elderly
Dean Norman, MD
2:10 PM-2:50 PM Alzheimer’s: Update for 2013
Jane Sillman, MD (Read Bio)
2:50 PM-3:30 PM Hematological Disorders in the Elderly
Michael Rosove, MD (Read Bio)
Session 17: Primary Care Challenges

1:30 PM-2:10 PM The Dizzy Patient
James Foody, MD, FACP (Read Bio)
2:10 PM-2:50 PM Irritable Bowel Syndrome
Marvin Derezin, MD (Read Bio)
2:50 PM-3:30 PM Controversies in Cancer Screening
Patrick Dowling, MD (Read Bio)

Additional Opportunities

 
Product Theater
11
AM
12
PM
11:35 AM-12:20 PM
Exposing Sodium Glucose Cotransporters (SGLTs): A Hidden Contributor To Persistent Hyperglycemia in Type 2 Diabetes
Brought to you by: Boehringer Ingelheim & Eli Lilly

11:35 AM-12:20 PM
Helicobacter pylori: Importance of Appropriate Testing and Management
Brought to you by: OAPI - Medical Device Division

11:35 AM-12:20 PM
Expanding Therapeutic Options in Mild to Moderate Alzheimer’s Disease
Brought to you by: Novartis Pharmaceuticals

11:35 AM-12:20 PM
LIVALO®: A Clinical Update
Brought to you by: Kowa Pharmaceuticals and Lilly USA

11:35 AM-12:20 PM
Exocrine Pancreatic Insufficiency (EPI)
Brought to you by: AbbVie

11:35 AM-12:20 PM
Improving Lung Function in COPD Patients: A Treatment Update
Brought to you by: Forest Pharmaceuticals, Inc.

12
PM
1
PM
12:40 PM-1:25 PM
A Paradigm Shift In The Treatment of Thrombosis
Brought to you by: Janssen Pharmaceuticals, Inc.

12:40 PM-1:25 PM
Redefining the Use of Basal Insulin: Focus on Hypoglycemia
Brought to you by: Novo Nordisk Inc.

12:40 PM-1:25 PM
Pneumococcal Disease in Adults 50+: A Prevention Option for Your Patients
Brought to you by: Pfizer Inc.

 
Product Theater
9
AM
9:00 AM-9:30 AM
VASCEPA® A New Therapy for the Treatment of Severe Hypertriglyceridemia
Brought to you by: Amarin Pharma, Inc.

9:00 AM-9:30 AM
Complications of Cirrhosis in the Age of Quality Health Measures
Brought to you by: Salix Pharmaceuticals, Inc.

9:00 AM-9:30 AM
Reducing the Risk of Stroke in Patients with Nonvalvular Atrial Fibrillation
Brought to you by: Pfizer Inc.

11
AM
12
PM
11:35 AM-12:20 PM
Individualizing Treatment for Your Asthma and Exercise-Induced Bronchospasm Patients
Brought to you by: Teva Respiratory

11:35 AM-12:20 PM
Nebulization for the Maintenance Treatment of COPD: When, Why, and Where?
Brought to you by: Mylan Specialty

11:35 AM-12:20 PM
Inflammatory Back Pain Recognition and Diagnosis
Brought to you by: AbbVie

11:35 AM-12:20 PM
Improving Glycemic Control Through DPP-4 Inhibition: Treatment Considerations for Adult Patients with Type 2 Diabetes
Brought to you by: Boehringer Ingelheim & Eli Lilly

11:35 AM-12:20 PM
A Low-Volume Formulation for the Treatment of Hypogonadism
Brought to you by: AbbVie

12
PM
1
PM
12:40 PM-1:25 PM
A Clinical Review of LINZESS
Brought to you by: Forest Pharmaceuticals, Inc.

12:40 PM-1:25 PM
Allergic Rhinitis: Addressing the Unmet Needs
Brought to you by: Teva Respiratory

12:40 PM-1:25 PM
Alternative Fuel for the Alzheimer’s Brain: Helping to Improve Memory and Cognition
Brought to you by: Accera, Inc.

12:40 PM-1:25 PM
A Case-Based Approach to Treating OAB: Including Landmark Study Results
Brought to you by: Pfizer Inc.

 
Product Theater
9
AM
9:00 AM-9:30 AM
A New Treatment Option for Type 2 Diabetes
Brought to you by: Janssen Pharmaceuticals, Inc.

9:00 AM-9:30 AM
Dupuytren’s Contracture in Adults With a Palpable Cord: Clinical Overview and Treatment Options
Brought to you by: Auxilium Pharmaceuticals, Inc.

9:00 AM-9:30 AM
Recognizing and Treating Moderate to Severe Alzheimer’s Disease in the Primary Care Setting
Brought to you by: Forest Pharmaceuticals, Inc.

11
AM
12
PM
11:35 AM-12:20 PM
Acne Matters: Tips to Treat and Manage Acne
Brought to you by: Galderma Laboratories LP

11:35 AM-12:20 PM
Evaluating and Treating Patients with Overactive Bladder
Brought to you by: Astellas Pharma U.S., Inc.

11:35 AM-12:20 PM
How to Initiate Short-Acting Insulin in the Primary Care Setting
Brought to you by: Novo Nordisk Inc.

11:35 AM-12:20 PM
A Novel Treatment Option for Chronic Weight Management
Brought to you by: Eisai, Inc.

11:35 AM-12:20 PM
Focus on the Goal of Anticoagulation in Patients With NVAF: Reduction of Ischemic Stroke
Brought to you by: Boehringer Ingelheim Pharmaceuticals, Inc.

Accreditation

Harvard Medical School 50x61

Current Clinical Issues in Primary Care

The educational program, Current Clinical Issues in Primary Care, is developed by the Course Development Committee of Harvard Medical School and the David Geffen School of Medicine at UCLA. All decisions about the program content and faculty are made exclusively by the Course Development Committee. It is the mission of the Course Development Committee to develop, present, and promote an educational opportunity that is timely, relevant, free of commercial influence, and of the highest quality. To that end, we welcome your comments about how better to serve your needs.

Credits Type Accreditation Statement Designation Statement
19 AMA PRA Category 1 Credits™ The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Harvard Medical School designates this live educational activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
Pri-Med Institute 93x91

Primary Care Updates

This educational program is conceived and created in accordance with Accreditation Council for Continuing Medical Education (ACCME) Accreditation Criteria, the ACCME Standards for Commercial Support℠, and ACCME Policies. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME’s Advisory Boards and its expert review partner, Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.

Track 1

Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education (which includes 3.375 hours of pharmacology).

Primary Care Updates

Track 2

Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education (which includes 3.375 hours of pharmacology).

Primary Care Updates

Track 3

Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education (which includes 3.375 hours of pharmacology).

Keynote Speakers

John Halamka, MD

Presenting on:

Holly Atkinson, MD (Read Bio)

Presenting on:

  • Should Medical Professionalism Include Advocacy?
    Friday (May 03, 2013), 7:45 AM-8:45 AM

Martin Shapiro, MD, PhD

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Thursday, May 2 8:30 AM–2:30 PM
Friday, May 3 8:30 AM–2:30 PM
Saturday, May 4 8:30 AM–2:00 PM

The Pri-Med Exhibit Hall is your chance to learn about and compare over 175 of the health care industry’s latest products, treatments, and technologies in one place.


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Amazing Charts*

Visit the #1-rated EHR Amazing Charts in booth 631 to watch a product demo and enter for a chance to win a Windows 8 tablet.

Download a FREE trial and get FREE Pri-Med 2014 registration: While you’re in session, we’ll load the full version of Amazing Charts on your laptop* and give you a 1:1 demo when you return to pick it up. Amazing Charts presentation schedule:

May 2–4
9:00 AM Intro to EHR
11:30 AM Intro to EHR
NOON Meaningful Use
12:30 PM Intro to EHR
1:00 PM Intro to EHR

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

Exhibit Floor Highlights

Presentation Theaters

Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Lunchtime workshops in the Presentation Theaters will focus on ways to boost revenue by adding ancillary products and services to your practice. Come and learn from some of the leading experts in the industry.


Watch this video for five tips on getting the most out of your Pri-Med experience.


mobile_app

Exhibitor List

Company Name Booth Number
AbbVie 230
Accessory Mania 753
Akeso Health Sciences 352
Alzheimers Association 810
Amazing Charts 631
American Academy of Anti-Aging Medicine 959
American Express 844
Army Medical Recruiting 439
AspirinWorks by Corgenix 830
AstraZeneca 533
Aureus Medical Group 816
Balance Back 617
Bionix Medical Technologies 222
Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA, LLC 301
Boston Heart Diagnostics 808
Bridges to Recovery 714
California Academy of Physician Asst 702
Calmoseptine 348
Carlson Laboratories 238
Cell Science Systems/ ALCAT 832
CME Corner / MCM Education 412
Critical Patient Care, Inc. 615
CryoSurgery, Inc 700
Daiichi Sankyo, Inc. 319
Dermalogix Partners Inc 500
Dr. Riba's Health Club 825
Ellman International, LLC 417
e-MDs 600
Forest Pharmaceuticals, Inc. 331
Galderma Laboratories LP 245
HAE: Learn About It, Talk About It 313
Hawaiian Moon 746
HemoCue, Inc. 902
Heritage Provider Network 553
Ideal Protein 547
I-Medical Consulting LLC 831
International Tree Nut Council Nutrition Research & Education Foundation 809
Kaiser Permanente 940
Kowa Pharmaceuticals 409
Lippincott Williams & Wilkins 100
Los Angeles County Sheriff's Department 836
Marketplace Scrubs and Labcoats 648
Medelita 646
Merck 347
Micro Direct, Inc. 733
Molina Medical Group 944
Mylan Specialty 951
Neilmed Pharmaceuticals, Inc. 817
New York Times 239
Novo Nordisk Inc. 509
Nu-Skin 501
OA Systems, Inc. 741
Office Ally 716
Pfizer Inc. 431
Planned Parenthood 934
Pri-Med Recharge Lounge 339
Qiagen, Inc. 112
Ringadoc 949
Sanofi Pasteur Inc. 800
Sebamed USA 811
Shader Productions 845
Summit Doppler Systems 516
Take Care Health Systems 818
Takeda Pharmaceuticals U.S.A. Inc. 109
Teva Respiratory 515
The Wall Street Journal 717
Tutto/Mascot Metropolitan Inc 853
Ultimate Creations 849
Verathon Medical 315
Vital Nutrients 552
Watermark Medical 344
Your Energy Systems LLC 353
Company Name Booth Number
Accera, Inc. 601
AIBioTech 961
Altamed Health Services 840
Amarin Pharma, Inc. 101
AmazingCharts.com 623
American College of Physicians 827
Argus Medical Management 737
Army National Guard 843
Astellas Pharma U.S., Inc. 216
Atherotech 801
Auxilium Pharmaceuticals, Inc. 614
Biofilm, Inc. 725
Bio-Oil 723
Boiron 401
Boston Scientific Corporation 953
Bristol-Myers Squibb 240
California Walnut Commission 930
Cardinal Health - Neuro Care Technologies Group 812
Casa Colina Centers for Rehabilitation 948
Chobani 835
Concentra 932
CryoProbe 503
Cynosure Inc 602
Dannon Company Inc 701
Doximity 709
Dyax Corporation 938
Elsevier Medical Books 447
FloChec 833
FRONTRUNNERS BOARD REVIEW 813
Genova Diagnostics, Inc 947
HAP Diet 110
health match bc 253
Hemosure 838
HydraFacial MD® - Edge Systems Corp. 603
i-Lipo / Chromogenex 541
Infinite Therapeutics 757
Janssen Pharmaceuticals, Inc. 450
Kareo 937
Laclede Inc 410
Loma Linda University Health Care 824
Maico Diagnostics 108
Master Profiles 823
MedTech Associates 453
Merrill Lynch 647
Midmark Corporation 638
MPR 246
Navajo Jewelry & Crafts 848
New Balance Athletic Shoes 651
Novartis Pharmaceuticals 423
Novo Nordisk Inc. 523
Nutramax Laboratories, Inc. 502
OAPI- Medical Device Division 309
Personna 957
Physician Financials 945
Prime Clinical Systems Inc 735
Pri-Med Visitor Center 639
Registry of Physician Specialists 546
Salix Pharmaceuticals, Inc. 248
Scarf King 749
Sensa Products, LLC 841
Southwest Medical Books 350
Sybe Medical Management 826
Take Shape For Life 715
Televox Software, Inc. 414
The Gideons International 748
Trident Case 952
Ultimate Creations 847
UltraScope 251
ViroPharma Incorporated 548
Vitamix 649
WynnPharm Inc. 408
Zanfel Laboratories, Inc. 539
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Anaheim Convention Center
800 W Katella Ave
Anaheim, CA 92802-3496
(714) 765-8950

Important Parking Information
The Anaheim Convention Center parking lots have reached capacity. Please proceed to the Disney Toy Story parking lot, located off of Harbor Boulevard.

After you have parked, proceed to Registration for your name badge and conference materials in Hall D on level 1.

Watch this video for five tips on getting the most out of your Pri‑Med experience.

video